Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | January 22, 2025 |
| PDB ID ▲ | UniProt ID | Title | Descriptor |
|---|---|---|---|
| 7MZN | P0DTC2 | SARS-CoV-2 receptor binding domain bound to Fab PDI 231 | |
| 7MZN | 7MZN | SARS-CoV-2 receptor binding domain bound to Fab PDI 231 | |
| 7MZQ | A0A2X2BLR9 | Crystal structure of the UcaD lectin-binding domain in complex with fucose | |
| 7MZR | A0A2X2BLR9 | Crystal structure of the UcaD lectin-binding domain in complex with glucose | |
| 7MZS | A0A2X2BLR9 | Crystal structure of the UcaD lectin-binding domain in complex with galactose | |
| 7MZT | P00736 | Borrelia burgdorferi BBK32-C in complex with an autolytic fragment of human C1r at 4.1A | |
| 7MZT | O50835 | Borrelia burgdorferi BBK32-C in complex with an autolytic fragment of human C1r at 4.1A | |
| 7N04 | 7N04 | Crystal structure of the apo F240 antibody fragment | |
| 7N0A | 7N0A | Structure of Human Leukaemia Inhibitory Factor with Fab MSC1 | |
| 7N0A | P15018 | Structure of Human Leukaemia Inhibitory Factor with Fab MSC1 | |
| 7N0G | P0DTC2 | CryoEm structure of SARS-CoV-2 spike protein (S-6P, 1-up) in complex with sybodies (Sb45) | |
| 7N0G | 7N0G | CryoEm structure of SARS-CoV-2 spike protein (S-6P, 1-up) in complex with sybodies (Sb45) | |
| 7N0H | P0DTC2 | CryoEM structure of SARS-CoV-2 spike protein (S-6P, 2-up) in complex with sybodies (Sb45) | |
| 7N0H | 7N0H | CryoEM structure of SARS-CoV-2 spike protein (S-6P, 2-up) in complex with sybodies (Sb45) | |
| 7N0U | P15494 | Complex of recombinant Bet v 1 with Fab fragment of REGN5713 | |
| 7N0U | 7N0U | Complex of recombinant Bet v 1 with Fab fragment of REGN5713 | |
| 7N19 | P01903 | DR3 in complex with Aspergillus nidulans NAD-dependent histone deacetylase hst4 peptide | |
| 7N19 | Q5Y7D1 | DR3 in complex with Aspergillus nidulans NAD-dependent histone deacetylase hst4 peptide | |
| 7N19 | 7N19 | DR3 in complex with Aspergillus nidulans NAD-dependent histone deacetylase hst4 peptide | |
| 7N1H | A0A0C4MX98 | CryoEM structure of Venezuelan equine encephalitis virus VLP in complex with the LDLRAD3 receptor | |
| 7N1H | A2AR95 | CryoEM structure of Venezuelan equine encephalitis virus VLP in complex with the LDLRAD3 receptor | |
| 7N1I | A0A0C4MX98 | CryoEM structure of Venezuelan equine encephalitis virus VLP | |
| 7N1Q | P0DTC2 | Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants | |
| 7N1T | P0DTC2 | Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants | |
| 7N1U | P0DTC2 | Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants | |
| 7N1V | P0DTC2 | Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants | |
| 7N1W | P0DTC2 | Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants | |
| 7N1X | P0DTC2 | Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants | |
| 7N1Y | P0DTC2 | Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants | |
| 7N28 | I6NF57 | Cryo-EM structure of broadly neutralizing V2-apex-targeting antibody J033 in complex with HIV-1 Env | |
| 7N28 | 7N28 | Cryo-EM structure of broadly neutralizing V2-apex-targeting antibody J033 in complex with HIV-1 Env | |
| 7N2N | A3F718 | TCR-antigen complex AS4.2-PRPF3-HLA*B27 | |
| 7N2N | P61769 | TCR-antigen complex AS4.2-PRPF3-HLA*B27 | |
| 7N2N | 7N2N | TCR-antigen complex AS4.2-PRPF3-HLA*B27 | |
| 7N2O | A3F718 | AS4.2-YEIH-HLA*B27 | |
| 7N2O | P61769 | AS4.2-YEIH-HLA*B27 | |
| 7N2O | 7N2O | AS4.2-YEIH-HLA*B27 | |
| 7N2P | A3F718 | AS4.3-RNASEH2b-HLA*B27 | |
| 7N2P | P61769 | AS4.3-RNASEH2b-HLA*B27 | |
| 7N2P | 7N2P | AS4.3-RNASEH2b-HLA*B27 | |
| 7N2Q | A3F718 | AS4.3-YEIH-HLA*B27 | |
| 7N2Q | P61769 | AS4.3-YEIH-HLA*B27 | |
| 7N2Q | 7N2Q | AS4.3-YEIH-HLA*B27 | |
| 7N2R | A3F718 | AS4.3-PRPF3-HLA*B27 | |
| 7N2R | P61769 | AS4.3-PRPF3-HLA*B27 | |
| 7N2R | 7N2R | AS4.3-PRPF3-HLA*B27 | |
| 7N2S | A3F718 | AS3.1-PRPF3-HLA*B27 | |
| 7N2S | P61769 | AS3.1-PRPF3-HLA*B27 | |
| 7N2S | 7N2S | AS3.1-PRPF3-HLA*B27 | |
| 7N3I | P0DTC2 | Crystal structure of the SARS-CoV-2 receptor binding domain in complex with the human neutralizing antibody Fab fragment C098 |
